Balversa 4MG tabs

Ended Awarded Last action

Contract number
36C26024F0443
Awardee
Awarding agency
Obligated
$17,643

Award facts

Contract value 100% obligated
$17,642.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Carrollton, TX 75010, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., for the pharmaceutical product BALVERSA 4MG TABS. The $17,642.95 order was issued against Janssen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract (FSS-61-IB) and has a completion date of June 30, 2024. Janssen Biotech Inc. is a for-profit manufacturer of specialty medications, including oncology drugs, that provides products to the VA and other federal agencies. The delivery order supports VHA's efforts to procure needed pharmaceuticals for veteran healthcare programs, with no set-aside designation indicated. Janssen holds a $3.7 million single award blanket purchase agreement (BPA) under the FSS-61-IB contract, as well as a $3.1 billion multiple award Pharmaceuticals and Drugs Federal Supply Schedule contract, which enables VHA buying offices to issue firm fixed price task orders for oncology medications.

Quick answers

Who was awarded contract 36C26024F0443?

36C26024F0443 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on June 6, 2024.

How much is contract 36C26024F0443 worth?

The government has obligated $17,643 on 36C26024F0443.

Is contract 36C26024F0443 an order under another contract?

Yes. 36C26024F0443 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26024F0443 competed?

The extent of competition for 36C26024F0443 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award